Organization | Heart Care Foundation

Heart Care Foundation Report issue

Foundation Phase 3 Phase 4

Founded: Kochi Kerala India (2005)

Organization Overview

First Clinical Trial

2005

NCT00403910

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (7)

amlodipine (norvasc) (1 trial)

bisoprolol (zebeta) (1 trial)

carvedilol (coreg) (1 trial)

clonidine (catapres) (1 trial)

furosemide (lasix) (1 trial)

ramipril (altace) (1 trial)

telmisartan (micardis) (1 trial)

Drugs in Phase 3 Trials (4)

canrenone (Contaren) (1 trial)

cyclosporine (sandimmune) (1 trial)

linagliptin (tradjenta) (1 trial)

sargramostim (leukine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Heart Failure (Phase 3)

Hypertension (Phase 4)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 11